Medtronic Total Non-Operating Income/Expense 2010-2024 | MDT
Medtronic annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Medtronic total non-operating income/expense for the quarter ending October 31, 2024 was $-0.036B, a 38.46% increase year-over-year.
- Medtronic total non-operating income/expense for the twelve months ending October 31, 2024 was $-0.255B, a 97.67% increase year-over-year.
- Medtronic annual total non-operating income/expense for 2024 was $-0.307B, a 153.72% increase from 2023.
- Medtronic annual total non-operating income/expense for 2023 was $-0.121B, a 48.51% decline from 2022.
- Medtronic annual total non-operating income/expense for 2022 was $-0.235B, a 60.1% decline from 2021.
| Medtronic Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024 | $-307 |
| 2023 | $-121 |
| 2022 | $-235 |
| 2021 | $-589 |
| 2020 | $-736 |
| 2019 | $-1,071 |
| 2018 | $-965 |
| 2017 | $-781 |
| 2016 | $-1,025 |
| 2015 | $-280 |
| 2014 | $-108 |
| 2013 | $-504 |
| 2012 | $-603 |
| 2011 | $-633 |
| 2010 | $-770 |
| 2009 | $-1,393 |
| Medtronic Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024-10-31 | $-36 |
| 2024-07-31 | $-10 |
| 2024-04-30 | $-198 |
| 2024-01-31 | $-11 |
| 2023-10-31 | $-26 |
| 2023-07-31 | $-72 |
| 2023-04-30 | $-13 |
| 2023-01-31 | $-18 |
| 2022-10-31 | $-9 |
| 2022-07-31 | $-81 |
| 2022-04-30 | $-69 |
| 2022-01-31 | $-70 |
| 2021-10-31 | $-70 |
| 2021-07-31 | $-26 |
| 2021-04-30 | $-38 |
| 2021-01-31 | $-57 |
| 2020-10-31 | $-405 |
| 2020-07-31 | $-89 |
| 2020-04-30 | $-111 |
| 2020-01-31 | $-60 |
| 2019-10-31 | $-57 |
| 2019-07-31 | $-508 |
| 2019-04-30 | $-654 |
| 2019-01-31 | $-172 |
| 2018-10-31 | $-189 |
| 2018-07-31 | $-56 |
| 2018-04-30 | $-203 |
| 2018-01-31 | $-409 |
| 2017-10-31 | $-166 |
| 2017-07-31 | $-187 |
| 2017-04-30 | $-249 |
| 2017-01-31 | $-180 |
| 2016-10-31 | $-173 |
| 2016-07-31 | $-179 |
| 2016-04-30 | $-441 |
| 2016-01-31 | $-176 |
| 2015-10-31 | $-217 |
| 2015-07-31 | $-191 |
| 2015-04-30 | $28 |
| 2015-01-31 | $-81 |
| 2014-10-31 | $-171 |
| 2014-07-31 | $-56 |
| 2014-04-30 | $176 |
| 2014-01-31 | $-70 |
| 2013-10-31 | $-90 |
| 2013-07-31 | $-124 |
| 2013-04-30 | $-37 |
| 2013-01-31 | $-63 |
| 2012-10-31 | $-332 |
| 2012-07-31 | $-72 |
| 2012-04-30 | $-184 |
| 2012-01-31 | $-100 |
| 2011-10-31 | $-178 |
| 2011-07-31 | $-141 |
| 2011-04-30 | $-107 |
| 2011-01-31 | $-150 |
| 2010-10-31 | $-337 |
| 2010-07-31 | $-39 |
| 2010-04-30 | $154 |
| 2010-01-31 | $-204 |
| 2009-10-31 | $-114 |
| 2009-07-31 | $-606 |
| 2009-04-30 | $-651 |
| 2009-01-31 | $-87 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $102.865B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.757B | 25.10 |
| Stryker (SYK) | United States | $136.750B | 30.82 |
| Boston Scientific (BSX) | United States | $131.731B | 37.87 |
| EssilorLuxottica (ESLOY) | France | $109.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.732B | 27.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.382B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.810B | 18.57 |
| ResMed (RMD) | United States | $33.540B | 27.56 |
| Terumo (TRUMY) | Japan | $28.681B | 40.51 |
| Koninklijke Philips (PHG) | Netherlands | $23.480B | 17.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.795B | 13.24 |
| Insulet (PODD) | United States | $18.017B | 71.75 |
| Baxter (BAX) | United States | $14.940B | 9.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.606B | 38.65 |
| Bio-Rad Laboratories (BIO) | United States | $9.131B | 31.03 |
| Demant (WILYY) | Denmark | $8.251B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.174B | 14.35 |
| Haemonetics (HAE) | United States | $3.938B | 19.22 |
| ICU Medical (ICUI) | United States | $3.868B | 36.83 |
| Prestige Consumer Healthcare (PBH) | United States | $3.840B | 19.10 |
| Perrigo (PRGO) | Ireland | $3.547B | 10.44 |
| Envista Holdings (NVST) | United States | $3.289B | 24.50 |
| QuidelOrtho (QDEL) | United States | $3.029B | 19.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.863B | 18.36 |
| Neogen (NEOG) | United States | $2.587B | 29.85 |
| LeMaitre Vascular (LMAT) | United States | $2.057B | 49.98 |
| Green Thumb Industries (GTBIF) | United States | $1.724B | 30.17 |
| AtriCure (ATRC) | United States | $1.482B | 0.00 |
| InMode (INMD) | Israel | $1.424B | 8.57 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.386B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.305B | 9.33 |
| BioLife Solutions (BLFS) | United States | $1.214B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.066B | 0.00 |
| Owens & Minor (OMI) | United States | $0.991B | 7.74 |
| CeriBell (CBLL) | United States | $0.926B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.840B | 14.81 |
| Evolus (EOLS) | United States | $0.704B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.680B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 26.20 |
| Omeros (OMER) | United States | $0.570B | 0.00 |
| Surmodics (SRDX) | United States | $0.567B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.463B | 0.00 |
| Quanterix (QTRX) | United States | $0.415B | 0.00 |
| Valneva SE (VALN) | France | $0.384B | 0.00 |
| ZimVie (ZIMV) | United States | $0.382B | 32.16 |
| Biote (BTMD) | United States | $0.328B | 7.18 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
| Cerus (CERS) | United States | $0.292B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.289B | 0.00 |
| High Tide (HITI) | Canada | $0.269B | 110.67 |
| OraSure Technologies (OSUR) | United States | $0.264B | 17.70 |
| Zynex (ZYXI) | United States | $0.249B | 52.07 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.208B | 14.37 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Brainsway (BWAY) | Israel | $0.180B | 95.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.152B | 0.00 |
| Jin Medical (ZJYL) | China | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.59 |
| Quipt Home Medical (QIPT) | United States | $0.125B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.072B | 37.00 |
| Jushi Holdings (JUSHF) | United States | $0.065B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.060B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.049B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Safety Shot (SHOT) | United States | $0.045B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.027B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.84 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |